This inventor holds 40 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Nanoparticle Delivery Systems. Top assignees: Barnes Jewish Hospital, Washington University, Bristol-Myers Squibb Medical Imaging, Inc.. Active years: 1986-2024.
Location History:
- Kirkwood, MO (US) (1986)
- Evanston, IL (US) (1997)
- Creve Coeur, MO (US) (1999)
- St. Louis, MO (US) (1997 - 2024)
Company Filing History:
18 out of 36 
16 out of 1,375 
3 out of 12 
Years Active: 1986-2024
Areas of Expertise:
Title: The Innovations of Gregory M Lanza
Introduction
Gregory M Lanza is a prominent inventor based in St. Louis, Missouri, known for his significant contributions to the field of medicine and drug delivery systems. With an impressive portfolio of 37 patents, Lanza has developed innovative techniques and compositions that enhance the effectiveness of pharmaceuticals. His work has had a substantial impact on both research and clinical applications.
Latest Patents
Among Lanza's latest innovations are patent applications focusing on prodrug compositions and prodrug nanoparticles. The essence of these inventions lies in their ability to optimize drug delivery. The present invention encompasses prodrug compositions, nanoparticles comprising one or more prodrugs, and methods of use thereof. This innovative approach can lead to more efficient treatments and improved patient outcomes.
Career Highlights
Throughout his career, Gregory M Lanza has been associated with renowned institutions such as Barnes Jewish Hospital and Washington University. His work in these establishments has fostered an environment that promotes cutting-edge research and clinical application of his inventions, further advancing the field of medicine.
Collaborations
Lanza's contributions have been enhanced through collaborations with notable colleagues, including Samuel A. Wickline and Dipanjan Pan. These partnerships have allowed him to expand the scope and effectiveness of his research, resulting in groundbreaking advancements in drug delivery systems.
Conclusion
Gregory M Lanza continues to be a pivotal figure in scientific innovation. His prolific patent portfolio and collaborative spirit demonstrate his commitment to advancing medical technology. As his research progresses, Lanza's inventions are likely to play a crucial role in shaping the future of drug delivery and treatment methodologies.